Clinical Trials Browser

Phase 2 × Ovarian Cancer Recurrent × Bevacizumab × Clear all

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Cancer Recurrent